Abiopharma

📋 FRANCIS LO (Officer) plans to sell 64K shares of ADAPTIVE BIOTECHNOLOGIES CORPORATION (at $15.76 each, total $1.0M) Filed: Jan 12, 2026 | ID: 000355

(99% Neutral) Health Catalyst Inc (HCAT) Reports Q1 2026 Financial Results

📋 KYLE PISKEL (Officer) plans to sell 11K shares of ADAPTIVE BIOTECHNOLOGIES CORPORATION (at $15.76 each, total $175K) Filed: Jan 12, 2026 | ID: 000351

Director Prange Karen 🟢 acquired 18.7K shares of Outset Medical, Inc. (OM) Transaction Date: Jan 09, 2026 | Filing ID: 000007

White Albert G III 🟡 adjusted position in 9.4K shares (1 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

📋 Rodman David Malcom (Officer) plans to sell 6K shares of Mineralys Therapeutics, Inc. (at $32.32 each, total $205K) Filed: Jan 12, 2026 | ID: 000038

Sheffield Holly R 🟡 adjusted position in 3.8K shares (3 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

📋 Levy Adam Scott (Officer) plans to sell 11K shares of Mineralys Therapeutics, Inc. (at $32.14 each, total $346K) Filed: Jan 12, 2026 | ID: 000037

McBride Daniel G 🟡 adjusted position in 6.7K shares (3 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

📋 Congleton Jon (Officer) plans to sell 16K shares of Mineralys Therapeutics, Inc. (at $32.62 each, total $530K) Filed: Jan 12, 2026 | ID: 000036

Andrews Brian G 🟡 adjusted position in 1.9K shares (1 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

(90% Positive) Exelixis Inc (EXEL) Announces Enrollment Update for results Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Director Kaye Jack 🟡 adjusted position in 6.4K shares (1 derivative) of uniQure N.V. (QURE) at $27.28 Transaction Date: Jan 09, 2026 | Filing ID: 000013

📋 Nagendran Sukumar (Officer) plans to sell 200K shares of Taysha Gene Therapies, Inc. (at $4.98 each, total $996K) Filed: Jan 12, 2026 | ID: 000011

Lippoldt Darin 🟡 adjusted position in 0 shares (1 derivative) of NEUROCRINE BIOSCIENCES INC (NBIX) at $35.99 Transaction Date: Jan 08, 2026 | Filing ID: 000004